Company: BDRX
Filing Date: 2025-12-08
Form Type: F-1/A
Source: 0001214659-25-017719
Chunk: 26

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-08
Form: F-1/A
Chunk 26
---
 that may result in a downward
adjustment to the exercise price, subject to a floor price, and a corresponding increase in the number of Depositary Shares issuable upon
exercise therefor, such that the aggregate exercise price would remain unchanged. As a result of such features, the number of Depositary
Shares issuable upon exercise of the Series L Warrants may increase significantly. If NASDAQ determines the terms of this offering raise
public interest concerns due to the dilutive nature of the transaction, or any other reason, NASDAQ may issue a determination letter to
delist our Depositary Shares pursuant to its discretionary authority under NASDAQ Listing Rule 5101. In that event, even if we were to
timely request a hearing with respect to NASDAQ’s determination to delist our Depositary Shares, NASDAQ may still impose an immediate
halt on the trading of our Depositary Shares pursuant to NASDAQ Listing Rule 4120(a)(5) pending the outcome of such hearing. If trading
in our Depositary Shares were to be halted or if NASDAQ were to determine to delist our Depositary Shares, investors could lose all or
part of their investment and our ability to raise additional capital through the public or private sale of equity securities would be
adversely affected.

| 16 |

This offering may cause the price of our Depositary Shares to decline and fall below the minimum bid price requirement required by the NASDAQ Listing Rules, which could result in our Depositary Shares being delisted from The NASDAQ Capital Market. A delisting of our Depositary Shares from The NASDAQ Capital Market could adversely affect our ability to raise additional capital through the public or private sale of equity securities, the ability of investors to dispose of Depositary Shares or obtain accurate quotations as to the market value of our Depositary Shares and the price and value of our Depositary Shares.

Our
Depositary Shares are currently listed on The NASDAQ Capital Market. Continued listing of a security on The NASDAQ Capital Market is conditioned
upon compliance with various continued listing standards. In particular, the requirements for The NASDAQ Capital Market impose a minimum
$1.00 per share bid price requirement. To comply with this requirement, the closing price for our Depositary Shares must not fall below
$1.00 for a 30 consecutive trading day period. If we are unable to maintain a minimum closing price of $1.00 per Depositary Share for
the preceding 30 consecutive trading days, we will receive a deficiency letter from